Researchers at Kansas State University have developed an improved treatment for lung cancer.
According to a university release Tuesday, project collaborators recently completed the first procedure in Australia as part of a clinical study. The procedure involves improved bronchoscopic microwave ablation treatment which officials hope could treat small lung tumors.
K-State collaborated with Royal Melbourne Hospital, phenoMapper LLC and Australian Healthcare Solutions on the clinical study, which was reportedly “straightforward and required skills that all interventional pulmonologists would possess,” according to Royal Melbourne professor of medicine Daniel Steinfort.
The phenoWave system’s underlying technology was jointly developed by the research team led by K-State engineer Punit Prakash and industry partner phenoMapper LLC under a National Cancer Institute academic-industry partnership R01 grant.
